40 likes | 109 Views
Horizons-AMI-final 3 year results.
E N D
Horizons-AMI-final 3 yearresults Objective: to evaluate the effectiveness and safety of heparin plus GP IIB/IIIA vs bivalirudinand (1:1) paclitaxel-elutingstents vs bare-metalstents (3:1)Study: prospective, open-label randomised trialPopulation: patients >18 years, with ST-segment MI within 12h afteronset of symptomsundergoing PCIEndpoint: MACE at 3 years
Horizons-AMI-final 3 yearresults Conclusion the safety and efficacy of bivalirudinissuperior to heparin plus GP IIB/IIIA at 3 years, and Paclitaxel has lower rate of targetlesionrevascularization Stone Lancet 2011;377:2193-204